effect of vitamin D in treatment of men with sexual dysfunctio

Not Applicable

• Conditions: Sexual dysfunction.; Impotence of organic origin

• Registration Number: IRCT201612252342N5
• Lead Sponsor: Vice chancellor for research, Mazandaran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Male
• Target Recruitment: 55

Inclusion Criteria

Men with erectile dysfunction diagnosis by urologist
Exclusion criteria: Age<20 and >60, underline disease include: depression, anxiety, drug abuse, heart failure, pectoral angina, hypertension, stroke, dementia, seizure, Parkinson, Cushing syndrome, drugs induced sexual dysfunction: SSRIs, anti-androgens, opioids, alcohol, cimetidine, spironolactone, thiazide, ketoconazole, beta-blockers, methyldopa, clonidine, metoclopramide, phenothiazine's and TCA.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Serum levels of testosterone. Timepoint: at baseline and monthly over 3 months. Method of measurement: laboratory blood tests.;Sexual function based on IIEF-5 questionnaires. Timepoint: at baseline and monthly over 3 months. Method of measurement: questionnaires.;Sexual function based on IIEF-15 questionnaires. Timepoint: at baseline and monthly over 3 months. Method of measurement: questionnaires.

Secondary Outcome Measures

Name	Time	Method
Serum level of FSH. Timepoint: at baseline and monthly over 3 months. Method of measurement: blood tests.;Serum level of LH. Timepoint: at baseline and monthly over 3 months. Method of measurement: blood tests.;Serum level of prolactin. Timepoint: at baseline and monthly over 3 months. Method of measurement: blood tests.